Format

Send to

Choose Destination
See comment in PubMed Commons below
Endocrinol Metab Clin North Am. 1999 Jun;28(2):423-38, viii.

Insulin-lowering therapeutic modalities for polycystic ovary syndrome.

Author information

1
Department of Medicine, Pritzker School of Medicine, University of Chicago, Illinois, USA.

Abstract

This article summarizes the relationship between insulin and androgen excess, with a focus on what is known regarding two related issues in polycystic ovary syndrome: (1) defects in insulin secretion in PCOS and their role in the development of glucose intolerance in this population; and (2) pharmacologic interventions designed to attenuate hyperinsulinemia and its sequelae in PCOS.

PMID:
10352927
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center